NCT03347708 - Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 26, 2018

Primary Completion Date

February 1, 2022

Study Completion Date

November 10, 2022

Conditions

Degenerative Disc Disease

Interventions

BIOLOGICAL

IDCT

Discogenic Cells + Sodium Hyaluronate Vehicle

DRUG

Saline Solution

Sodium Chloride Solution

DRUG

Sodium Hyaluronate

Sodium Hyaluronate Vehicle

Trial Locations (14)

10022

Ainsworth Institute of Pain Management, New York

23235

Virginia iSpine, Richmond

28204

Carolina Neurosurgery & Spine Associates, Charlotte

29406

Clinical Trials of South Carolina, Charleston

35235

Alabama Clinical Therapeutics, LLC, Birmingham

38120

Semmes Murphey, Memphis

41017

Otrimed, Edgewood

63017

Orthopedic Center of St. Louis, Chesterfield

71101

Spine Institute of Louisiana, Shreveport

73013

Clinical Investigations, LLC, Edmond

84020

Physicians' Research Options, LLC, Draper

90033

University of Southern California, Los Angeles

90403

Source Healthcare, Santa Monica

92037

UC San Diego CIRM Alpha Stem Cell Clinic, San Diego